A Swiss company with a rare license to produce weed and medical cannabis is up for sale.
The company’s purpose is the breeding, research, production, and trade of plants for medical and pharmaceutical application as well as the production, distribution, and trade of pharmaceutical and medical products.
The company may establish branch offices and subsidiaries at home and abroad, participate in other companies at home and abroad, acquire, hold, exploit, and sell intellectual property rights, and carry out all business that is directly or indirectly related to its purpose.
The company may acquire, encumber, sell, and manage real estate at home and abroad. It may also undertake financing for its own or third-party accounts, and enter into guarantees and sureties for subsidiaries and third parties.
Permits/Authorisations
The company holds all necessary permits in Switzerland for the medical cannabis sector.
Thanks to these permits, it is able to cultivate itself, store, purchase goods, import, trade, commission, and distribute its products directly within Switzerland.
The permits were granted by Swissmedic, the responsible Swiss Authorising and Controlling Authority for therapeutic products. The production facility was inspected and approved by the Cantonal Pharmacist and has been approved by the GMP (Good Manufacturing Practice) department of the Regional Institute for Medicines (RHI), thereby fulfilling all regulatory requirements for operation.
Production Field
A multi-room cultivation facility, including dedicated mother plant areas optimized for consistent, pharmaceutical-grade production.
Resellers / Network
Through its control over the entire production chain and wholesale trade, this firm has the unique opportunity to tap into the entire Swiss market for medical and pharmaceutical cannabis.
– 1,800 pharmacies in Switzerland: offers a premier foundation for significant commercial growth. Our successful early market entry via leading Swiss pharmacy channels demonstrates market readiness of the business model and supports national scaling.
Operational execution will be led by an experienced sales expert with an established network within the pharmacy sector. This individual will be specifically responsible for building and managing distribution channels. To ensure maximum market penetration, we are currently evaluating the optimal structure for this collaboration—whether as an independent intermediary or through a permanent employment contract.
– Potential partnership with a B2B pharmaceutical wholesaler (e.g., Galexis and Co.).
Licence
| Original |
English |
| Betriebsbewilligung zum Anbau von Cannabis für medizinische Zwecke. |
Operating License for the Cultivation of Cannabis for Medical Purposes. |
| (Art. 2 Bst. h BetmKV) |
(Art. 2 lit. h Narcotics Control Ordinance) |
| • Betriebsbewilligung zum Umgang mit kontrollierten Substanzen. |
• Operating License for the Handling of Controlled Substances. |
| (Art. 2 Bst. h BetmKV) |
(Art. 2 lit. h Narcotics Control Ordinance) |
| • Betriebsbewilligung Arzneimittel |
• Medicinal Products Operating License |
| (Bewilligungsnummer XXXXXX-XXXXXX) |
(License Number XXXXXX-XXXXXX) |
| Die Bewilligung wird für folgende Tätigkeiten erteilt: |
The license is granted for the following activities: |
| – Herstellung von Arzneimitteln |
– Manufacturing of Medicinal Products |
| – Grosshandel mit Arzneimitteln |
– Wholesale of Medicinal Products |
| Gesetzliche Grundlagen: |
Legal Basis: |
| – Heilmittelgesetz (HMG; SR 812.21) |
– Therapeutic Products Act (HMG; SR 812.21) |
| – Arzneimittel-Bewilligungsverordnung (AMBV; SR 812.212.1) |
– Ordinance on the Licensing of Medicinal Products (AMBV; SR 812.212.1) |
| – Arzneimittelverordnung (VAM; SR 812.212.21) |
– Medicinal Products Ordinance (VAM; SR 812.212.21) |
| – Lohnerstellung laut Heilmittelgesetz (HMG) |
– Contract Manufacturing (Toll Manufacturing) according to the Therapeutic Products Act (HMG) |
Infrastructure
The company benefits from a cost-efficient production by leasing space and being able to optimally utilize the existing infrastructure.
Its landlord recently offered it the prospect of leasing additional space in the building. A 10-year rental agreement has been secured at very favorable conditions.
Human Resources
There are 2 employees and 3 freelancers. Its team has been in place for 10 years and possesses comprehensive experience.
Rapid Scalability
Thanks to the existing know-how and the possibility of leasing additional production space the company can quickly respond to demand.
Swiss Made
This allows it to access the international market with its high-quality flowers. To the company’s knowledge, no Swiss player is currently active on the global market with their own products.
Description
A Swiss company with a rare license to produce weed and medical cannabis is up for sale.
The company’s purpose is the breeding, research, production, and trade of plants for medical and pharmaceutical application as well as the production, distribution, and trade of pharmaceutical and medical products.
The company may establish branch offices and subsidiaries at home and abroad, participate in other companies at home and abroad, acquire, hold, exploit, and sell intellectual property rights, and carry out all business that is directly or indirectly related to its purpose.
The company may acquire, encumber, sell, and manage real estate at home and abroad. It may also undertake financing for its own or third-party accounts, and enter into guarantees and sureties for subsidiaries and third parties.
Permits/Authorisations
The company holds all necessary permits in Switzerland for the medical cannabis sector.
Thanks to these permits, it is able to cultivate itself, store, purchase goods, import, trade, commission, and distribute its products directly within Switzerland.
The permits were granted by Swissmedic, the responsible Swiss Authorising and Controlling Authority for therapeutic products. The production facility was inspected and approved by the Cantonal Pharmacist and has been approved by the GMP (Good Manufacturing Practice) department of the Regional Institute for Medicines (RHI), thereby fulfilling all regulatory requirements for operation.
Production Field
A multi-room cultivation facility, including dedicated mother plant areas optimized for consistent, pharmaceutical-grade production.
Resellers / Network
Through its control over the entire production chain and wholesale trade, this firm has the unique opportunity to tap into the entire Swiss market for medical and pharmaceutical cannabis.
– Potential partnership with a B2B pharmaceutical wholesaler (e.g., Galexis and Co.).
Licence
Infrastructure
The company benefits from a cost-efficient production by leasing space and being able to optimally utilize the existing infrastructure.
Its landlord recently offered it the prospect of leasing additional space in the building. A 10-year rental agreement has been secured at very favorable conditions.
Human Resources
There are 2 employees and 3 freelancers. Its team has been in place for 10 years and possesses comprehensive experience.
Rapid Scalability
Thanks to the existing know-how and the possibility of leasing additional production space the company can quickly respond to demand.
Swiss Made
This allows it to access the international market with its high-quality flowers. To the company’s knowledge, no Swiss player is currently active on the global market with their own products.
Basic Details
Target Price:
CHF 0
Business ID:
L#20251050
Country
Switzerland
Detail
Similar Businesses
Published on December 5, 2025 at 4:36 pm. Updated on January 21, 2026 at 7:54 am
Historical Virgin Fiber Folding Boxboard Manufacturer
€125,000,000
Manufacturing
50-Year-Old Historical Women’s apparel Manufacturing Business
€6,000,000
Manufacturing
40 Year Old Pharmaceutical Manufacturing Business
$40,000,000
Manufacturing, Pharma
80-Years-Old Historical Italian Pasta Manufacturing Business
TBD
Manufacturing
Full-cycle confectionery and bakery Manufacturing Business
$2,000,000
Manufacturing
Established Indian Textile Manufacturer
$35,000,000
Manufacturing
PREVIOUS PROPERTY
12 MW Hydropower Plant (2 × 6 MW Units) RTB + GOV PPA
NEXT PROPERTY
96,7 MWp Operational Solar Photovoltaic Power Station